Citations

Mayo Clinic

Showing 10 of 108585 citations.

Hospital transfer associated with increased mortality after endovascular revascularization for acute ischemic stroke
Rinaldo, Lorenzo , Brinjikji, Waleed , McCutcheon, Brandon A., Bydon, Mohamad , Cloft, Harry J. , Kallmes, David F. , Cloft, Harry, Rabinstein, Alejandro A.

Journal of NeuroInterventional Surgery | December 24, 2016 | Volume: 9 | Issue: 12 | Pages: 1166-1172

10.1136/neurintsurg-2016-012824 | PMID 27986846 Get It

Background Patients with an acute ischemic stroke (AIS) due to large vessel occlusion often require transfer to an endovascular center for treatment. Objective To assess the effect of hospital transfer on outcomes after endovascular revascularization. Methods Outcomes of endovascular revascularization were compared between directly admitted and transferred patients using data from a national database and our own institution. Results 118 institutions within the database reported outcomes of 8533 inpatient admissions for endovascular treatment of AIS. Mortality rate (14.9% vs 18.6%; p=0.049) and mortality index (1.1 vs 1.6; p=0.048) were significantly lower among directly admitted patients than among transferred patients. Within our institutional cohort of 140 patients who underwent endovascular therapy, directly admitted patients had a significantly faster time to revascularization than transferred patients (277.4 vs 420.4 min; p≤0.0001). Among transferred patients, an increasing distance of transferred hospital to our home institution was associated with an increasing risk of mortality (unit OR=1.26, 95% CI 1.07 to 1.54; p=0.0061). Conclusions Outcomes of revascularization may improve with methods to identify patients with large vessel occlusion before hospital admission, thus increasing the likelihood of initial triage to a comprehensive stroke center for patients eligible for endovascular intervention.
Shared Decision-Making following Disclosure of Coronary Heart Disease Genetic Risk: Results from a Randomized Clinical Trial
Jouni, Hayan, Haddad, Raad A., Marroush, Tariq S. , Brown, Sherry‐Ann , Kruisselbrink, Teresa , Austin, Erin , Behnken, Emma , Chaudhry, Rajeev , Kruisselbrink, Teresa M, Austin, Erin E, Shameer, Khader, Behnken, Emma M, Shameer, Khader , Montori, Víctor M. , Kullo, Iftikhar J.

Journal of Investigative Medicine | December 24, 2016 | Volume: 65 | Issue: 3 | Pages: 681-688

10.1136/jim-2016-000318 | PMID 27993947 Get It

Whether disclosure of genetic risk for coronary heart disease (CHD) influences shared decision-making (SDM) regarding use of statins to reduce CHD risk is unknown. We randomized 207 patients, age 45–65 years, at intermediate CHD risk, and not on statins, to receive the 10-year risk of CHD based on conventional risk factors alone (n=103) or in combination with a genetic risk score (n=104). A genetic counselor disclosed this information followed by a physician visit for SDM regarding statin therapy. A novel decision aid was used in both encounters to disclose the CHD risk estimates and facilitate SDM regarding statin use. Patients reported their decision quality and physician visit satisfaction using validated surveys. There were no statistically significant differences between the two groups in the SDM score, satisfaction with the clinical encounter, perception of the quality of the discussion or of participation in decision-making and physician visit satisfaction scores. Quantitative analyses of a random subset of 80 video-recorded encounters using the OPTION5 scale also showed no significant difference in SDM between the two groups. Disclosure of CHD genetic risk using an electronic health record-linked decision aid did not adversely affect SDM or patients’ satisfaction with the clinical encounter. Trial registration number NCT01936675; Results.
Acute oxygenator failure: a new presentation of heparin-induced thrombocytopenia in a patient undergoing venovenous extracorporeal membrane oxygenation support
Ratzlaff, Robert A. , Ripoll, Juan G. , Kassab, Lena L., Díaz-Gómez, José L , Díaz‐Gómez, José L.

BMJ Case Reports | December 24, 2016 | Volume: 2016 | Issue: No issue available | Pages: bcr2016218179

10.1136/bcr-2016-218179 | PMID 27986695 Get It

A 58-year-old man with medical history of thrombocytopenia was admitted to an outside hospital for a 6-day history of worsening dyspnoea requiring mechanical ventilator support. He was transferred to our institution for extracorporeal membrane oxygenation (ECMO) given his refractory hypoxaemia. On arrival, H1N1 influenza virus was confirmed and all measures to improve oxygenation were ineffective. Thus, the decision was made to start venovenous (VV)-ECMO. Although a low baseline platelet count was recognised (60–70×109/L), a sudden further decrease occurred (30×109/L) and platelet transfusion was initiated. A substantial increase in the pressure across the ECMO oxygenator was identified, and the diagnosis of type II heparin-induced thrombocytopenia was suspected and confirmed. Heparin was discontinued, the oxygenator was exchanged and argatroban was used for anticoagulation. After 28 days on VV-ECMO support, the decision was made to withdraw organ support in conjunction with the patient and family wishes.
Mallory Weiss syndrome is not associated with hiatal hernia: a matched case–control study
Keihanian, Tara , Dauer, Ryan M., Lukens, Frank , Sussman, Daniel A. , Corral, Juan E. , Lukens, Frank J., Kröner, Paul T.

Scandinavian Journal of Gastroenterology | December 24, 2016 | Volume: 52 | Issue: 4 | Pages: 462-464

10.1080/00365521.2016.1267793 | PMID 28007004 Get It

Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
Baumgartner, Helmut , Bermejo, Javier , Chambers, John B. , Edvardsen, Thor , Lancellotti, Patrizio , LeFevre, Melissa, Miller, Fletcher A., Miller, Fletcher, Hung, Judy W. S. , Goldstein, Steven A. , Otto, Catherine M , Bermejo, Javier

European Heart Journal - Cardiovascular Imaging | December 24, 2016 | Volume: 18 | Issue: 3 | Pages: 254-275

10.1093/ehjci/jew335 | PMID 28363204 Get It

Echocardiography is the key tool for the diagnosis and evaluation of aortic stenosis. Because clinical decision-making is based on the echocardiographic assessment of its severity, it is essential that standards are adopted to maintain accuracy and consistency across echocardiographic laboratories. Detailed recommendations for the echocardiographic assessment of valve stenosis were published by the European Association of Echocardiography and the American Society of Echocardiography in 2009. In the meantime, numerous new studies on aortic stenosis have been published with particular new insights into the difficult subgroup of low gradient aortic stenosis making an update of recommendations necessary. The document focuses in particular on the optimization of left ventricular outflow tract assessment, low flow, low gradient aortic stenosis with preserved ejection fraction, a new classification of aortic stenosis by gradient, flow and ejection fraction, and a grading algorithm for an integrated and stepwise approach of artic stenosis assessment in clinical practice.
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Gregory, Philip A. , Fernandes, Rayzel C. , Denis, Iza , Wang, Qingqing , Townley, Scott L. , Zhao, Shuang G. , Hanson, Adrienne R. , Pickering, Marie , Armstrong, Heather , Lokman, Noor A. , Ebrahimie, Esmaeil , Jenkins, Robert B. , Karnes, R. Jeffrey , Ross, Ashley E. , Den, Robert B. , Klein, Eric A. , Ramshaw, Hayley S. , Williams, Elizabeth D. , Zoubeidi, Amina , Goodall, Gregory J. , Feng, Felix Y. , Butler, Lisa M. , Tilley, Wayne D. , Selth, Luke A. , Das, Rajdeep , Townley, Scott L. , Zhao, Shuang G , Davicioni, Elai , N., Kim , Den, Robert B , Klein, Eric A

Cancer Research | December 23, 2016 | Volume: 77 | Issue: 4 | Pages: 1021-1034

10.1158/0008-5472.can-16-2529 | PMID 28011622 Get It

Abstract Serum levels of miR-194 have been reported to predict prostate cancer recurrence after surgery, but its functional contributions to this disease have not been studied. Herein, it is demonstrated that miR-194 is a driver of prostate cancer metastasis. Prostate tissue levels of miR-194 were associated with disease aggressiveness and poor outcome. Ectopic delivery of miR-194 stimulated migration, invasion, and epithelial–mesenchymal transition in human prostate cancer cell lines, and stable overexpression of miR-194 enhanced metastasis of intravenous and intraprostatic tumor xenografts. Conversely, inhibition of miR-194 activity suppressed the invasive capacity of prostate cancer cell lines in vitro and in vivo. Mechanistic investigations identified the ubiquitin ligase suppressor of cytokine signaling 2 (SOCS2) as a direct, biologically relevant target of miR-194 in prostate cancer. Low levels of SOCS2 correlated strongly with disease recurrence and metastasis in clinical specimens. SOCS2 downregulation recapitulated miR-194–driven metastatic phenotypes, whereas overexpression of a nontargetable SOCS2 reduced miR-194–stimulated invasion. Targeting of SOCS2 by miR-194 resulted in derepression of the oncogenic kinases FLT3 and JAK2, leading to enhanced ERK and STAT3 signaling. Pharmacologic inhibition of ERK and JAK/STAT pathways reversed miR-194–driven phenotypes. The GATA2 transcription factor was identified as an upstream regulator of miR-194, consistent with a strong concordance between GATA2 and miR-194 levels in clinical specimens. Overall, these results offer new insights into the molecular mechanisms of metastatic progression in prostate cancer. Cancer Res; 77(4); 1021–34. ©2016 AACR.
Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia
Nandakumar, Vijayalakshmi, Hebrink, Deanne, Jenson, Paige E., Jenson, Paige, Kottom, Theodore, Kottom, Theodore J. , Limper, Andrew H.

Infection and Immunity | December 23, 2016 | Volume: 85 | Issue: 3 | Pages: No page available

10.1128/iai.00939-16 | PMID 27993972 Get It

ABSTRACTWe explored differential polarization of macrophages during infection using a rat model ofPneumocystispneumonia. We observed enhanced pulmonary M1 macrophage polarization in immunosuppressed (IS) hosts, but an M2 predominant response in immunocompetent (IC) hosts followingPneumocystis cariniichallenge. Increased inflammation and inducible nitric oxide synthase (iNOS) levels characterized the M1 response. However, macrophage ability to produce nitric oxide was defective. In contrast, the lungs of IC animals revealed a prominent M2 gene signature, and these macrophages effectively elicited an oxidative burst associated with clearance ofPneumocystis. In addition, duringP. cariniiinfection the expression of Dectin-1, a critical receptor for recognition and clearance ofP. carinii, was upregulated in macrophages of IC animals but suppressed in IS animals. In the absence of an appropriate cytokine milieu for M2 differentiation,Pneumocystisinduced an M1 response bothin vitroandin vivo. The M1 response induced byP. cariniiwas plastic in nature and reversible with appropriate cytokine stimuli. Finally, we tested whether macrophage polarization can be modulatedin vivoand used to help manage the pathogenesis ofPneumocystispneumonia by adoptive transfer. Treatment with both M1 and M2 cells significantly improved survival ofP. carinii-infected IS hosts. However, M2 treatment provided the best outcomes with efficient clearance ofP. cariniiand reduced inflammation.
Faculty Opinions recommendation of Predicting the chances of a live birth after one or more complete cycles of in vitro fertilisation: population based study of linked cycle data from 113 873 women.
Coddington, Charles C. , Shenoy, Chandra C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 23, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726986323.793526534 Get It

Clinical and surgical management of a congenital Type II split cord malformation presenting with progressive cranial neuropathies: case report
Maloney, Patrick R. , Murphy, Meghan E. , Sullan, Molly J., Abel, Kathryn M. Van , Cofer, Shelagh A. , Cheville, John C. , Wetjen, Nicholas M. , Van Abel, Kathryn M

Journal of Neurosurgery: Pediatrics | December 23, 2016 | Volume: 19 | Issue: 3 | Pages: 349-353

10.3171/2016.9.peds15661 | PMID 28009225 Get It

Split cord malformation (SCM) is a rare abnormality of notochord development. The majority of cases occur in the thoracolumbar region, with more than 30 cases of cervical SCM reported. The clinical impact of SCMs involving the cervical cord is therefore largely unknown. In addition, the concomitant finding of brainstem involvement is presumably incompatible with life in the majority of patients, resulting in a paucity of data regarding this clinical scenario. In this paper the authors present the first case, to their knowledge, of an incomplete cervical SCM involving the brainstem and discuss its clinical impact, diagnosis, and management.
029 Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie’s Disease
Yafi, F., Hatzichristodoulou, Georgios , Knoedler, C.J., Trost, L., Sikka, S.C., Hellstrom, W.J.G., Trost, L., Sikka, Suresh C. , Hellstrom, Wayne J.G.

The Journal of Sexual Medicine | December 23, 2016 | Volume: 14 | Issue: Supplement_1 | Pages: S13-S14

10.1016/j.jsxm.2016.11.031 Get It